Abstract
Both epigenetics and genetic alterations are associated with cancer formation. Identification of prognostic biomarkers, DNA-methylation-mediated miRNAs, is an important step towards developing therapeutic treatment of cancer. Ovarian cancer is one of the most lethal cancers among the females, it was selected for the present study. The TCGA database provides large volume of data for cancer study, which is useful if one can combine different batches of datasets; hence, higher confident results can be obtained. There are several issues arise in data integration, i.e., missing data problem, data heterogeneity problem and the need of construct an automatic platform to reduce human intervention.
Method. Both the normal and ovarian tumor datasets were obtained from the TCGA database. To interpolate the missing methylation values, we employed the KNN imputation method. Simulation tests were performed to obtain the optimal k value. We utilized meta-analysis to minimize the heterogeneity problem and derived statistical significant DNA methylation-mediated-miRNA events. Finally, a semi-automatic pipeline was constructed to facilitate the imputation and meta-analysis studies; thus, identify potential epigenetic biomarkers in a more efficient manner.
Results. Both epigenetic- and TF-mediated effects were examined, which allow us to remove false positive events. The methylation-mediated-miRNA pairs identified by our platform are in-line with literature studies.
Conclusion. We have demonstrated that our imputation and meta-analysis pipeline led to better performance and efficiency in detecting methylation-mediated-miRNA pairs. Furthermore, this study reveals the association between aberrant DNA methylation and alternated miRNA expression, which contributes to better knowledge of the role of epigenetics regulation in ovarian cancer formation.
E.B. Wijaya and E. Lim—Equal contribution.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Feinberg, A.P.: Genome-scale approaches to the epigenetics of common human disease. Virchows Arch. Int. J. Pathol. 456(1), 13–21 (2010). https://doi.org/10.1007/s00428-009-0847-2
Jia, Y., Guo, M.: Epigenetic changes in colorectal cancer. Chin. J. Cancer 32(1), 21–30 (2013). https://doi.org/10.5732/cjc.011.10245
Monteiro, F.L., Vitorino, R., Wang, J., et al.: The histone H2A isoform Hist2h2ac is a novel regulator of proliferation and epithelial–mesenchymal transition in mammary epithelial and in breast cancer cells. Cancer Lett. 396, 42–52 (2017). https://doi.org/10.1016/j.canlet.2017.03.007
Zhang, X., Dong, J., He, Y., et al.: miR-218 inhibited tumor angiogenesis by targeting ROBO1 in gastric cancer. Gene 615, 42–49 (2017)
U.S. Cancer Statistics Working Group: United States Cancer Statistics: 1999–2013 Incidence and Mortality Web-based Report. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, 11 February 2017. www.cdc.gov/uscs
Lujambio, A., Ropero, S., Ballestar, E., et al.: Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67, 1424–1429 (2007). https://doi.org/10.1158/0008-5472.can-06-4218
Monroig, P.C., Calin, G.A.: MicroRNA and epigenetics: diagnostic and therapeutic opportunities. Curr. Pathobiol. Rep. 1(1), 43–52 (2013)
Agustriawan, D., Huang, C.-H., Sheu, J.J.-C., et al.: DNA methylation-mediatedmicroRNA pathways in ovarian serous cystadenocarcinoma: a meta-analysis. Comput. Biol. Chem. 65, 154–164 (2016)
Biagioni, F., Ben-Noshe, N.B., Fontemaggi, G., et al.: miR-10b, a master inhibitor of the cell cycle, is down-regulated in human breast tumours. EMBO Mol. Med. 4(11), 1214–1229 (2012). https://doi.org/10.1002/emmm.201201483
Biagioni, F., Bossel, B.-M.N., Fontemaggi, G., et al.: The locus of microRNA-10b: a critical target for breast cancer insurgence and dissemination. Cell Cycle 12(15), 2371–2375 (2013). https://doi.org/10.4161/cc.25380
Chen, K., Liu, M.X., Mak, C.S.-L., et al.: Methylation-associated silencing of miR-193a-3p promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways. Theranostics 8(2), 423–436 (2018)
Delfino, K.R., Rodriguez-Zas, S.L.: Transcription factor-MicroRNA-target gene networks associated with ovarian cancer survival and recurrence. PLoS ONE 8(3), e58608 (2013). https://doi.org/10.1371/journal.pone.0058608
Guo, Y., Sheng, Q., Li, J., et al.: Large scale comparison of gene expression levels by microarrays and RNAseq using TCGA data. PLoS ONE 8(8), e71462 (2013). https://doi.org/10.1371/journal.pone.0071462
Tomczak, K., Czerwińska, P., Wiznerowicz, M.: The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp. Oncol. 19(1A), A68–A77 (2015). https://doi.org/10.5114/wo.2014.47136
Troyanskaya, O., Cantor, M., Sherlock, G., et al.: Missing value estimation methods for DNA microarrays. Bioinformatics 17(6), 520–525 (2001)
Xiang, Q., Dai, X., Deng, Y., et al.: Missing value imputation for microarray gene expression data using histone acetylation information. BMC Bioinform. 9, 252 (2008). https://doi.org/10.1186/1471-2105-9-252
Sung, Y.J., Schwander, K., Arnett, D.K., et al.: An empirical comparison of meta-analysis and mega-analysis of individual participant data for identifying gene-environment interactions. Genet. Epidemiol. 38, 369–378 (2014). https://doi.org/10.1002/gepi.21800
Batista, G.E.A.P.A., Monard, M.C.: A Study of K-Nearest Neighbor as an Imputation Method. HIS, University of São Paulo – USP, Brazil (2002)
Ahmadi-Nedushan, B.: An optimized instance based learning algorithm for estimation of compressive strength of concrete. Eng. Appl. Artif. Intell. 25(5), 1073–1081 (2012)
Kurum, E., Benayoun, B.A., Malhotra, A., et al.: Computational inference of a genomic pluripotency signature in human and mouse stem cells. Biol. Dir. 11, 47 (2016). https://doi.org/10.1186/s13062-016-0148-z
Chien, C.-H., Sun, Y.-M., Chang, W.-C., et al.: Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data. Nucleic Acids Res. 39(21), 9345–9356 (2011). https://doi.org/10.1093/nar/gkr604
Griffiths-Jones, S., Grocock, R.J., van Dongen, S., et al.: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34(Database issue), D140–D144 (2006). https://doi.org/10.1093/nar/gkj112
Borenstein, M., Hedges, L.V., Higgins, J.P., Rothstein, H.R.: Introduction to Meta-Analysis. Wiley, Chichester (2009)
Sung, H.Y., Yang, S.-D., Ju, W., Ahn, J.-H.: Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer. Exp. Mol. Med. 49, e335 (2017). https://doi.org/10.1038/emm.2017.62
Wang, J., Lu, M., Qiu, C., Cui, Q.: TransmiR: a transcription factor–microRNA regulation database. Nucleic Acids Res. 38(Database issue), D119–D122 (2010). https://doi.org/10.1093/nar/gkp803
Ruepp, A., Kowarsch, A., Schmidl, D., et al.: PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes. Genome Biol. 11(1), R6 (2010). https://doi.org/10.1186/gb-2010-11-1-r6
Jiang, Q., Wang, Y., Hao, Y., et al.: miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res. 37(Database issue), D98–D104 (2009). https://doi.org/10.1093/nar/gkn714
Ehrlich, M.: DNA hypomethylation in cancer cells. Epigenomics 1(2), 239–259 (2009). https://doi.org/10.2217/epi.09.33
Zhang, W., Barger, C.J., Eng, K.H., et al.: PRAME expression and promoter hypomethylation in epithelial ovarian cancer. Oncotarget 7(29), 45352–45369 (2016)
Armstrong, L.: Epigenetics. Garland Science, New York (2013)
Laios, A., O’Toole, S., Flavin, R., et al.: Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol. Cancer 7, 35 (2008). https://doi.org/10.1186/1476-4598-7-35
Shell, S., Park, S.-M., Radjabi, A.R., et al.: Let-7 expression defines two differentiation stages of cancer. Proc. Natl. Acad. Sci. U.S.A. 104(27), 11400–11405 (2007). https://doi.org/10.1073/pnas.0704372104
Acknowledgments
Dr. Chien-Hung Huang work is supported by the Ministry of Science and Technology (MOST) under the grant of MOST 106-2221-E-150-056. Dr. Ka-Lok Ng work is supported by the grants of MOST 106-2221-E-468-017, MOST 106-2632-E-468-002, and also supported under the grant from Asia University, 105-asia-1, and 106-asia-06. Dr. Jeffrey J. P. Tsai work is supported by the grant of MOST 106-2632-E-468-002. Mr. Ezra B. Wijaya work is supported by the grant of MOST 106-2221-E-468 -017.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this paper
Cite this paper
Wijaya, E.B., Lim, E., Agustriawan, D., Huang, CH., Tsai, J.J.P., Ng, KL. (2018). Utilize Imputation Method and Meta-analysis to Identify DNA-Methylation-Mediated microRNAs in Ovarian Cancer. In: Jansson, J., MartÃn-Vide, C., Vega-RodrÃguez, M. (eds) Algorithms for Computational Biology. AlCoB 2018. Lecture Notes in Computer Science(), vol 10849. Springer, Cham. https://doi.org/10.1007/978-3-319-91938-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-91938-6_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-91937-9
Online ISBN: 978-3-319-91938-6
eBook Packages: Computer ScienceComputer Science (R0)